Afksendiyos Kalangos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Afksendiyos Kalangos has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Dominique Vala
Division of Cardiovascular Surgery, University Hospital of Geneva, Medical School, University of Geneva, Geneva, Switzerland
10 shared publications- Mustafa Cikirikcioglu
Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
8 shared publications Bernard Faidutti
Clinic for Cardiovascular Surgery, Department of Anesthesiology, Department of Pathology, University Hospital of Geneva, Geneva, Switzerland
5 shared publicationsMaurice Beghetti
5 shared publicationsMustafa Cikirikcioglu
5 shared publicationsDominique Didier
Radiology, University Hospital of Geneva, Geneva, Switzerland
4 shared publications
Latest Publications
- 1 December 2017
- Published by Oxford University Press (OUP)
- p. 757-762
Aneurysmal diseases
Abdominal aortic aneurysm (AAA) is a pathology commonly observed in older adults with an estimated incidence of around 5% of men older than 65 years. The precise aetiology of this disease is still not fully uncovered; most aneurysms are classified as degenerative with complex interaction between genetic predisposition and environmental factors. Most AAA remain asymptomatic until they rupture. At this stage, they have a 90% mortality rate. Screening programmes are the best method to detect AAA and thus treating them electively. Open repair was once the gold standard of treatment, as no medical treatment has proven a clear benefit in reducing or stopping AAA growth. Recently endovascular repair; a new less invasive approach; has emerged and is rapidly replacing open repair with better mortality and morbidity rates.
- 1 December 2017
- Published by Oxford University Press (OUP)
- p. 757-762
Aneurysmal diseases
Abdominal aortic aneurysm (AAA) is a pathology commonly observed in older adults with an estimated incidence of around 5% of men older than 65 years. The precise aetiology of this disease is still not fully uncovered; most aneurysms are classified as degenerative with complex interaction between genetic predisposition and environmental factors. Most AAA remain asymptomatic until they rupture. At this stage, they have a 90% mortality rate. Screening programmes are the best method to detect AAA and thus treating them electively. Open repair was once the gold standard of treatment, as no medical treatment has proven a clear benefit in reducing or stopping AAA growth. Recently endovascular repair; a new less invasive approach; has emerged and is rapidly replacing open repair with better mortality and morbidity rates.
- 1 January 2015
- Published by Elsevier in Operative Techniques in Thoracic and Cardiovascular Surgery
- Vol. 20 (2) , 124-134
Mitral Annuloplasty Using A Biodegradable Annuloplasty Ring
- 1 January 2015
- Published by Elsevier in Operative Techniques in Thoracic and Cardiovascular Surgery
- Vol. 20 (2) , 124-134
Mitral Annuloplasty Using A Biodegradable Annuloplasty Ring
- Open Access
- 3 August 2014
- Published by Springer Nature in BMC Surgery
- Vol. 14 (1) , 48
Biodegradable materials for surgical management of infective endocarditis: new solution or a dead end street?
One third of patients with infective endocarditis will require operative intervention. Given the superiority of valve repair over valve replacement in many indications other than endocarditis, there has been increasing interest and an increasing number of reports of excellent results of valve repair in acute infective endocarditis. The theoretically ideal material for valve repair in this setting is non-permanent, “vanishing” material, not at risk of seeding or colonization. The goal of this contribution is to review currently available data on biodegradable materials for valve repair in infective endocarditis.
- 3 August 2014
- Published by Springer Nature in BMC Surgery
- Vol. 14 (1) , 48
Open AccessBiodegradable materials for surgical management of infective endocarditis: new solution or a dead end street?
One third of patients with infective endocarditis will require operative intervention. Given the superiority of valve repair over valve replacement in many indications other than endocarditis, there has been increasing interest and an increasing number of reports of excellent results of valve repair in acute infective endocarditis. The theoretically ideal material for valve repair in this setting is non-permanent, “vanishing” material, not at risk of seeding or colonization. The goal of this contribution is to review currently available data on biodegradable materials for valve repair in infective endocarditis.
- 1 May 2014
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 28 (4) , 1036.e1-1036.e3
Ascending Aorto-Superior Mesenteric Artery Bypass as a Surgical Option for Revascularization in Mesenteric Ischemia Associated with Type B Aortic Dissection
- 1 May 2014
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 28 (4) , 1036.e1-1036.e3
Ascending Aorto-Superior Mesenteric Artery Bypass as a Surgical Option for Revascularization in Mesenteric Ischemia Associated with Type B Aortic Dissection
- 1 April 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 97 (4) , e97-e99
Successful Treatment of Persistent Chylopericardium With Somatostatin After Operation on Ascending Aorta
- 1 April 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 97 (4) , e97-e99
Successful Treatment of Persistent Chylopericardium With Somatostatin After Operation on Ascending Aorta
- 8 January 2014
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 5 (1) , 128-130
Modified Transseptal Repair for Total Anomalous Pulmonary Venous Connection Repair in All Age Groups
Little data are available in late-presenting children with unobstructed totally anomalous pulmonary venous connection. Eleven patients underwent repair at a median age of 6.5 months using a modified transseptal approach to improve access and avoid circulatory arrest. There were no early or late deaths, and none of the patients presented pulmonary venous stenosis at a median follow-up of 8.7 years.
- 8 January 2014
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 5 (1) , 128-130
Modified Transseptal Repair for Total Anomalous Pulmonary Venous Connection Repair in All Age Groups
Little data are available in late-presenting children with unobstructed totally anomalous pulmonary venous connection. Eleven patients underwent repair at a median age of 6.5 months using a modified transseptal approach to improve access and avoid circulatory arrest. There were no early or late deaths, and none of the patients presented pulmonary venous stenosis at a median follow-up of 8.7 years.
- 10 October 2013
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 4 (4) , 385-391
Aortic Cusp Extension for Surgical Correction of Rheumatic Aortic Valve Insufficiency in Children
Surgical management of aortic insufficiency in the young is problematic because of the lack of an ideal valve substitute. Potential advantages of aortic valve repair include low incidences of thromboembolism and endocarditis, avoiding conduit replacements, the maintenance of growth potential, and improved quality of life. Aortic valve repair is still far from fulfilling the three key factors that have allowed the phenomenal development of mitral valve repair (standardization, reproducibility, and stable long-term results); however, techniques of aortic valve repair have been refined, and subsets of patients amenable to repair have been identified. We have focused on the oldest technique of aortic valve repair, cusp extension, focusing on children with rheumatic aortic insufficiency. Among 77 children operated from 2003 to 2007, there was one early death from ventricular failure and one late death from sudden cardiac arrhythmia. During a mean follow-up of 12.8 ± 5.9 years, there were 16 (20.5%) reoperations on the aortic valve, at a median of 3.4 years (range, 2 months to 18.3 years) from repair. Freedom from aortic valve reoperation was 96.2% ± 2.2% at 1 year, 94.9% ± 2.5% at 2 years, 88.5% ± 3.6% at 5 years, 81.7% ± 4.4% at 10 years, 79.7% ± 4.8% at 15 years, and 76.2% ± 5.7% at 20 years. Although aortic cusp extension is technically more demanding, it remains particularly more suitable in the context of evolving rheumatic aortic insufficiency in children with a small aortic annulus as a bridge surgical approach to late aortic valve replacement with a larger valvular prosthesis.
- 10 October 2013
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 4 (4) , 385-391
Aortic Cusp Extension for Surgical Correction of Rheumatic Aortic Valve Insufficiency in Children
Surgical management of aortic insufficiency in the young is problematic because of the lack of an ideal valve substitute. Potential advantages of aortic valve repair include low incidences of thromboembolism and endocarditis, avoiding conduit replacements, the maintenance of growth potential, and improved quality of life. Aortic valve repair is still far from fulfilling the three key factors that have allowed the phenomenal development of mitral valve repair (standardization, reproducibility, and stable long-term results); however, techniques of aortic valve repair have been refined, and subsets of patients amenable to repair have been identified. We have focused on the oldest technique of aortic valve repair, cusp extension, focusing on children with rheumatic aortic insufficiency. Among 77 children operated from 2003 to 2007, there was one early death from ventricular failure and one late death from sudden cardiac arrhythmia. During a mean follow-up of 12.8 ± 5.9 years, there were 16 (20.5%) reoperations on the aortic valve, at a median of 3.4 years (range, 2 months to 18.3 years) from repair. Freedom from aortic valve reoperation was 96.2% ± 2.2% at 1 year, 94.9% ± 2.5% at 2 years, 88.5% ± 3.6% at 5 years, 81.7% ± 4.4% at 10 years, 79.7% ± 4.8% at 15 years, and 76.2% ± 5.7% at 20 years. Although aortic cusp extension is technically more demanding, it remains particularly more suitable in the context of evolving rheumatic aortic insufficiency in children with a small aortic annulus as a bridge surgical approach to late aortic valve replacement with a larger valvular prosthesis.
- 1 May 2013
- Published by Elsevier in Cardiovascular Pathology
- Vol. 22 (3) , e50-e51
Comparison of synthetic small-calibre biodegradable vs. stable ePTFE vascular prosthesis after long-term implantation in the rat aorta
- 1 May 2013
- Published by Elsevier in Cardiovascular Pathology
- Vol. 22 (3) , e50-e51
Comparison of synthetic small-calibre biodegradable vs. stable ePTFE vascular prosthesis after long-term implantation in the rat aorta
- Open Access
- 1 October 2012
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 19 (4) , 373-375
Anuloplastia tricúspide con anillo biodegradable
- 1 October 2012
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 19 (4) , 373-375
Open AccessAnuloplastia tricúspide con anillo biodegradable
- 1 September 2012
- Vol. 21 (5) , 650-4
Triple valve repair in children with rheumatic heart disease: long-term experience.
Triple valve replacement has poor early and long-term results, particularly in children, and few data are available on triple valve repair. Herein are reported the single-center, long-term results of combined aortic, mitral, and tricuspid valve repair in rheumatic children. Ten children (mean age 12 +/- 3 years) with severe rheumatic aortic, mitral, and tricuspid regurgitation underwent triple valve repair over a 17-year period, using a tailored cusp extension to repair the aortic valve, and ring annuloplasty and Carpentier's techniques to repair the mitral and tricuspid valves. There were no early deaths. During a median follow up of 58 months (range: 3 months to 16 years), no late death occurred and four patients (40%) required reoperation at a median of three years (range: 2.7 to 12 years). Reoperations included one for mitral valve replacement, one for aortic valve replacement, and two for aortic and mitral valve replacements. Freedom from reoperation was 100% at one year, 63 +/- 17% at three, five, and 10 years, and 47 +/- 19% at 15 years. In this particularly challenging patient group, triple valve repair provided satisfactory initial and mid-term results, with a high burden of reoperation in the long term, allowing a median of three years of growth and subsequent placement of a larger valve at the time of actual valve replacement. This strategy might be considered a good palliative surgical approach.
- 1 September 2012
- Vol. 21 (5) , 650-4
Triple valve repair in children with rheumatic heart disease: long-term experience.
Triple valve replacement has poor early and long-term results, particularly in children, and few data are available on triple valve repair. Herein are reported the single-center, long-term results of combined aortic, mitral, and tricuspid valve repair in rheumatic children. Ten children (mean age 12 +/- 3 years) with severe rheumatic aortic, mitral, and tricuspid regurgitation underwent triple valve repair over a 17-year period, using a tailored cusp extension to repair the aortic valve, and ring annuloplasty and Carpentier's techniques to repair the mitral and tricuspid valves. There were no early deaths. During a median follow up of 58 months (range: 3 months to 16 years), no late death occurred and four patients (40%) required reoperation at a median of three years (range: 2.7 to 12 years). Reoperations included one for mitral valve replacement, one for aortic valve replacement, and two for aortic and mitral valve replacements. Freedom from reoperation was 100% at one year, 63 +/- 17% at three, five, and 10 years, and 47 +/- 19% at 15 years. In this particularly challenging patient group, triple valve repair provided satisfactory initial and mid-term results, with a high burden of reoperation in the long term, allowing a median of three years of growth and subsequent placement of a larger valve at the time of actual valve replacement. This strategy might be considered a good palliative surgical approach.